HADHA and hepatocellular carcinoma: On the one hand, miR-612 reduces HCC pseudopodia formation and inhibits metastasis and invasion through HADHA-mediated lipid reprogramming, which is consistent with clinical data that patients with low miR-612 levels and high HADHA levels have a poorer prognosis and shorter overall survival (Liu et al., 2020).